Supplementation of Pumpkin Seed Oil and SCFASs as a Prospective Biotherapeutic to Preserve Gut Natural Microbiota of Colitis Mice
Downloads
Background: Ulcerative Colitis (UC) is an inflammatory disease in the colon, due to the disruption of the interaction between the immune response and the intestinal microbiota in a genetically susceptible host. The imbalance between commensal and pathogenic intestinal microbiota promotes inflammation. This study aims to explore the efficacy of pumpkin seed oil and SCFAs in maintaining the intestinal microbiota in UC model mice. Methods: Four groups, K1, K2, K3, and K4, as health control given distilled water (K1); K2, K3, and K4 induced UC with 2% DSS, followed by administration of Short Chain Fatty Acids (SCFAs) (K3), supplementation of SCFAs and pumpkin seed oil (K4). The number of colonies measured microbiota diversity (log CFU/mL/g) in NA, EMB, MRSA, and McConkey media. Hemoglobin and hematocrit were also measured to assess anemia. Results: The average number of bacterial colonies that grew on NA, EMB, MRSA, and McConkey media in K4 was 7.65, 5.78, 7.85, and 6.20, respectively, and the average HB and hematocrit levels were 14.2 g/dL and 42%, respectively. There was greater microbiota diversity and lactobacillus bacteria in UC rats given pumpkin seed oil and SCFAs, with fewer Enterobacteriaceae and E. coli than in the UC model. The increase in HB and hematocrit levels also showed the same trend. Conclusion: Pumpkin seed oil at a dose of 100 mg/kg and SCFAs can be a prospective biotherapy for maintaining the balance of the natural microbiota and increasing HB levels.
Downloads
Matei-Lațiu MC, Gal AF, Rus V, Buza V, Martonos C, Lațiu C, et al. Intestinal Dysbiosis in Rats: Interaction between Amoxicillin and Probiotics, a Histological and Immunohistochemical Evaluation. Nutrients 2023;15:1–14. https://doi.org/10.3390/nu15051105.
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 2019;7. https://doi.org/10.3390/microorganisms7010014.
Wen X, Xie R, Wang HG, Zhang MN, He L, Zhang MH, et al. Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor four signaling pathway. World Journal of Gastroenterology 2023;29:4657–70. https://doi.org/10.3748/wjg.v29.i30.4657.
Lin MK, Yang YT, Lin LJ, Yu WH, Chen HY. Pulsatilla decoction suppresses matrix metalloproteinase-7-mediated leukocyte recruitment in dextran sulfate sodium-induced colitis mouse model. BMC Complementary Medicine and Therapies 2022;22:1–14. https://doi.org/10.1186/s12906-022-03696-w.
Meers GK, Bohnenberger H, Reichardt HM, Lühder F, Reichardt SD. Impaired resolution of dss-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells. PLoS ONE 2018;13:1–15. https://doi.org/10.1371/journal.pone.0190846.
Li L, Peng P, Ding N, Jia W, Huang C, Tang Y. Oxidative Stress, Inflammation, Gut Dysbiosis: What Can Polyphenols Do in Inflammatory Bowel Disease? Antioxidants 2023;12:1–27. https://doi.org/10.3390/antiox12040967.
Tan C, Wu Q, Wang H, Gao X, Xu R, Cui Z, et al. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes. Journal of Parenteral and Enteral Nutrition 2021;45:518–29. https://doi.org/10.1002/jpen.1861.
Nascimento R de P do, Moya AMTM, Machado AP da F, Geraldi MV, Diez-Echave P, Vezza T, et al. Review on the potential application of non-phenolic compounds from native Latin American food byproducts in inflammatory bowel diseases. Food Research International 2021;139. https://doi.org/10.1016/j.foodres.2020.109796.
Holota Y, Dovbynchuk T, Kaji I, Vareniuk I, Dzyubenko N, Chervinska T, et al. The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity. PLoS ONE 2019;14:1–25. https://doi.org/10.1371/journal.pone.0220642.
Monteros MJM, Galdeano CM, Balcells MF, Weill R, De Paula JA, Perdigón G, et al. Probiotic lactobacilli as a promising strategy to ameliorate disorders associated with intestinal inflammation induced by a non-steroidal anti-inflammatory drug. Scientific Reports 2021;11:1–15. https://doi.org/10.1038/s41598-020-80482-z.
Chang CS, Liao YC, Huang CT, Lin CM, Cheung CHY, Ruan JW, et al. Identification of a gut microbiota member that ameliorates DSS-induced colitis in intestinal barrier enhanced Dusp6-deficient mice. Cell Reports 2021;37. https://doi.org/10.1016/j.celrep.2021.110016.
Lee JG, Lee J, Lee A reum, Jo SV, Park CH, Han DS, et al. Impact of short-chain fatty acid supplementation on gut inflammation and microbiota composition in a murine colitis model. Journal of Nutritional Biochemistry 2022;101:108926. https://doi.org/10.1016/j.jnutbio.2021.108926.
Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids from Gut Microbiota in Gut-Brain Communication. Frontiers in Endocrinology 2020;11:1–14. https://doi.org/10.3389/fendo.2020.00025.
Pace F, Rudolph SE, Chen Y, Bao B, Kaplan DL, Watnick PI. The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection. Microbiology Spectrum 2021;9:1–12. https://doi.org/10.1128/spectrum.01369-21.
Zhang S, Dogan B, Guo C, Herlekar D, Stewart K, Scherl EJ, et al. Short chain fatty acids modulate the growth and virulence of pathosymbiont escherichia coli and host response. Antibiotics 2020;9:1–20. https://doi.org/10.3390/antibiotics9080462.
Liang L, Saunders C, Sanossian N. Food, gut barrier dysfunction, and related diseases : A new target for future individualized disease prevention and management 2023:1671–704. https://doi.org/10.1002/fsn3.3229.
Dempsey E, Corr SC. Lactobacillus spp. for Gastrointestinal Health: Current and Future Perspectives. Frontiers in Immunology 2022;13:1–15. https://doi.org/10.3389/fimmu.2022.840245.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms 2021;9:1–15. https://doi.org/10.3390/microorganisms9040697.
Hsiao PY, Weng MT, Chang CH, Huang LY, Tung CC, Leong YL, et al. Anemia in inflammatory bowel disease course is associated with patients’ worse outcome. Journal of the Formosan Medical Association 2023;122:549–56. https://doi.org/10.1016/j.jfma.2022.11.004.
Rieder F, Paul G, Schnoy E, Schleder S, Wolf A, Kamm F, et al. Hemoglobin and hematocrit levels in the prediction of complicated Crohn’s disease behavior - A cohort study. PLoS ONE 2014;9. https://doi.org/10.1371/journal.pone.0104706.
Copyright (c) 2025 The Indonesian Journal of Infectious Diseases
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
